Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04882449 · ClinicalTrials.gov registry record
Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events
A clinical trial, sponsored by Bodyport.
- Completed
- Registry status
- 329
- Enrollment target
NCT04882449 is a clinical trial that has completed, run by Bodyport. The registered enrollment target is 329 participants.
The verdict
NCT04882449 has completed, sponsored by Bodyport.
- COMPLETED
- Registry status
- 329 participants
- Enrollment target
Study Summary
The main goal of this study is to use data from the Bodyport Cardiac Scale to help detect of worsening heart failure (HF) early.
Interventions
- DEVICE Bodyport Cardiac Scale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 329 participants |
| Start Date | 2021-07-08 |
| Est. Completion | 2023-07-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04882449
The ClinicalTrials.gov registry entry for NCT04882449 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 329 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bodyport, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bodyport Cardiac Scale is the first listed.
NCT04882449 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04882449 about?
NCT04882449 is a clinical study titled "Surveillance and Alert-based Multiparameter Monitoring to Reduce Worsening Heart Failure Events". The main goal of this study is to use data from the Bodyport Cardiac Scale to help detect of worsening heart failure (HF) early.
What is the current status of trial NCT04882449?
This trial is currently completed. The enrollment target is 329 participants. The study started on 2021-07-08. Estimated completion is 2023-07-31.
What interventions are being tested in trial NCT04882449?
The interventions under investigation include: Bodyport Cardiac Scale (DEVICE).
Who is sponsoring clinical trial NCT04882449?
This trial is sponsored by Bodyport, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.